Found: 6
Select item for more details and to access through your institution.
Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Impaired myoblast differentiation and muscle IGF‐1 receptor signaling pathway activation after N‐glycosylation inhibition.
- Published in:
- FASEB Journal, 2024, v. 38, n. 13, p. 1, doi. 10.1096/fj.202400213RR
- By:
- Publication type:
- Article
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- Cell Biology & Toxicology, 2023, v. 39, n. 3, p. 795, doi. 10.1007/s10565-021-09640-x
- By:
- Publication type:
- Article
Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 3, p. 1, doi. 10.1007/s00018-022-04180-x
- By:
- Publication type:
- Article
N-glycosylation inhibition impairs C2C12 and L6 myoblast differentiation and IGF-1 signalling.
- Published in:
- European Journal of Translational Myology, 2023, v. 33, n. 2, p. 44, doi. 10.4081/ejtm.2023.11427
- By:
- Publication type:
- Article
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1654, doi. 10.3390/cancers11111654
- By:
- Publication type:
- Article